Chlorotrianisene (CTA), also known as tri-p-anisylchloroethylene (TACE) and sold under the brand name Tace among others, is a nonsteroidal estrogen related to diethylstilbestrol (DES) which was previously used in the treatment of menopausal symptoms and estrogen deficiency in women and prostate cancer in men, among other indications, but has since been discontinued and is now no longer available. (wikipedia.org)
Chlorotrianisene, also known as tri-p-anisylchloroethylene (TACE) or as tris(p-methoxyphenyl)chloroethylene, is a synthetic nonsteroidal compound of the triphenylethylene group. (wikipedia.org)
Estrogens1
As an example, chlorotrianisene produces gynecomastia in men, albeit reportedly to a lesser extent than other estrogens, while clomifene and tamoxifen do not and can be used to treat gynecomastia. (wikipedia.org)
Produces1
After menopause, when the body no longer produces estrogen, chlorotrianisene is used as a simple replacement of estrogen. (pharmacycode.com)
Drug1
Chlorotrianisene is the generic name of the drug and its INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name, and BANTooltip British Approved Name. (wikipedia.org)
Experience1
How was your experience with Chlorotrianisene? (rxwiki.com)
Benzestrol1
DES was sold under many names including Distilbène ®, Stilbetin ®, Stilboestrol-Borne ®, Benzestrol ®, Chlorotrianisene®, Estrobene® and Estrosyn® to name just a few. (desdaughter.com)